How Long Do Immunotherapy Side Effects Last? For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild. by Anna Goshua Worth the Wait Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients. by Sharon Tregaskis Our Own Words People with cancer and their loved ones find ways for their voices to be heard without filters. by Bradley Jones Survivor Profile Still in the Game ESPN reporter Holly Rowe worked through melanoma treatment. by Lindsey Konkel Q&A Dissecting Mental Illness Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain. by Marci A. Landsmann Pembrolizumab Shows Further Promise for Melanoma In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected. by Brad Jones Forward Look Tackling Drug Resistance Researchers are studing new ways to keep treatments working longer. by Stephen Ornes Survivor Profile Living in the Here and Now A metastatic melanoma survivor is hopeful but realistic as new treatments become available. by Jenny Song Forward Look Cancer Immunotherapies Continue to Make Headway Drugs that harness the power of the immune system gain new approvals. by Alexandra Goho Survivor Profile Knowing Her Options When Christina McEvoy was diagnosed with stage IV melanoma, she took the reins of her care, traveling more than 600 miles for treatment and returning home to help other melanoma survivors. by Melissa Davlin next Cancer Talk A Treatment That Came Just in Time Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma. by Laurie Adami More Data on COVID-19 Vaccination and Cancer Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients. by Anna Goshua Putting the Patient in the Driver’s Seat In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond. by Kevin McLaughlin A Closer Look at Sarcopenia Gastrointestinal oncologist and health services researcher Ryan Nipp discusses new research about how muscle quality correlates with cancer outcomes. by Ashley P. Taylor More Posts